MATR3 |
MATR3, KIAA0723: Matrin-3 |
ZNF267 |
ZNF267: Zinc finger protein 267 |
0.265 |
Evidence |
|
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
0.265 |
Evidence |
|
NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
0.265 |
Evidence |
|
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
RPS6KB1 |
IPI00216132 |
0.265 |
Evidence |
|
PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
0.265 |
Evidence |
|
RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.265 |
Evidence |
|
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
0.265 |
Evidence |
|
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
0.265 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
PAK4 |
PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
0.265 |
Evidence |
|
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
NRBP1 |
NRBP1, BCON3, NRBP: Nuclear receptor-binding protein |
0.265 |
Evidence |
|
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
MAP3K11 |
MAP3K11, MLK3, PTK1, SPRK: Mitogen-activated protein kinase kinase kinase 11 |
0.265 |
Evidence |
|
CDC34 |
CDC34, UBE2R1: Ubiquitin-conjugating enzyme E2 R1 |
HUWE1 |
HUWE1, KIAA0312, HSPC272, KIAA1578, UREB1: E3 ubiquitin-protein ligase HUWE1 |
0.265 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
0.265 |
Evidence |
|
MAPK6 |
MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.265 |
Evidence |
|
FLNA |
FLNA, FLN, FLN1: Filamin-A |
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
0.265 |
Evidence |
|
LPXN |
LPXN, LDLP: Leupaxin |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
0.265 |
Evidence |
|
RBM6 |
RBM6, DEF3: RNA-binding protein 6 |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
0.265 |
Evidence |
|
PLEK |
PLEK, P47: Pleckstrin |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
0.265 |
Evidence |
|
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.265 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
IL1RL1 |
IL1RL1, DER4, ST2, T1: Interleukin-1 receptor-like 1 precursor |
0.265 |
Evidence |
|
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
CFH |
CFH, HF, HF1, HF2: Complement factor H precursor |
0.265 |
Evidence |
|
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
0.265 |
Evidence |
|
HIVEP1 |
IPI00013444 |
MATR3 |
MATR3, KIAA0723: Matrin-3 |
0.265 |
Evidence |
|
PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.265 |
Evidence |
|